Immunogen (IMGN) Misses Q2 EPS by 2c
Immunogen (NASDAQ: IMGN) reported Q2 EPS of ($0.38), $0.02 worse than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Immunogen (NASDAQ: IMGN) reported Q2 EPS of ($0.38), $0.02 worse than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Immunogen (IMGN) click here.